Does CERITINIB Cause Interstitial lung disease? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with CERITINIB (ZYKADIA). This represents 0.8% of all adverse event reports for CERITINIB.
21
Reports of Interstitial lung disease with CERITINIB
0.8%
of all CERITINIB reports
8
Deaths
11
Hospitalizations
How Dangerous Is Interstitial lung disease From CERITINIB?
Of the 21 reports, 8 (38.1%) resulted in death, 11 (52.4%) required hospitalization, and 3 (14.3%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for CERITINIB.
What Other Side Effects Does CERITINIB Cause?
Malignant neoplasm progression (523)
Diarrhoea (452)
Death (391)
Nausea (381)
Vomiting (270)
Metastases to central nervous system (203)
Non-small cell lung cancer (183)
Fatigue (149)
Decreased appetite (139)
Dyspnoea (137)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CERITINIB Alternatives Have Lower Interstitial lung disease Risk?
CERITINIB vs CERLIPONASE ALFA
CERITINIB vs CERTICAN
CERITINIB vs CERTOLIZUMAB
CERITINIB vs CERTOLIZUMAB PEGOL
CERITINIB vs CERTOPARIN